Court: Supreme Court of the United States, No. 23-235 & 236
Case status: Pending. Oral Argument on March 26, 2024
Center involvement: Amicus Curiae
Date of filing: February 29, 2024

Respondent Alliance for Hippocratic Medicine (AHM) and other organizations of pro-life doctors challenged the FDA’s reduction of safeguards surrounding the distribution of the abortion-inducing drug mifepristone.  AHM asked the court to enjoin distribution of the drug, which induces a miscarriage in order to end a pregnancy.  Because the drug is now available without a prescription and can be taken without even visiting a doctor’s office, the number of women suffering serious and life-threatening complications has increased significantly.

The defendants argue that this lawsuit should not be heard because those bringing it have not been harmed by the FDA’s actions.  Our brief explains why the AHM and other organizations have standing to bring the suit on behalf of their members.  As our brief explains, the member physicians are doctors who object to abortion on moral and religious grounds.  This brief details how the FDA’s actions harm those doctors and why they have standing to bring this lawsuit.

Court Filings:
223-235 Amicus Brief of The Robertson Center for Constitutional Law